+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage



The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage



Human Immunology 68(6): 491-499



Administrative claims data facilitate ascertainment of outcomes not collected by the transplant registry and provide the opportunity to examine prescribed doses of immunosuppressive medications. Here, we examine the impact of human leukocyte antigen (HLA) matching on traditional outcomes, rejection and survival, and use novel methods to examine immunosuppresion doses and complication rates. The central hypothesis tested in this analysis is that HLA-matched recipients receive lower doses of immunosuppression and have fewer posttransplant complications. We break from tradition by examining HLA matching in both living and deceased donor kidney transplants. As secondary aims, we compare the relative impact of class I and II mismatches and describe outcomes achieved with older donors. Medicare claims linked to the United States Renal Data System database for 23,443 kidney transplants were included in the study. A total of 15,793 transplants were DR mismatched (DRMM), 5,340 manifested no DR mismatches (NODRMM), and 2,310 manifested no ABDR mismatches (NOABDRMM). Patients with NOABDRMM experienced lower adjusted risk of rejection (0.66, 95% confidence interval 0.59-0.74, P < 0.001) and lower hazard of graft loss (0.69, 0.61-0.77, P < 0.001) and death (0.76, 0.63-0.92, P < 0.001) compared with those with DRMM. The hazard of cardiac and diabetic complications was similar between recipients of NOADRMM and DRMM transplants, but the hazard of diarrhea was significantly lower (0.82, 0.73-0.92, P < 0.001) in patients with NOABDRMM. The 6-month dose of mycophenolate mofetil was lower in patients with NOABDRMM. This study validates previous studies that indicated significantly lower risks of rejection, graft loss, and death among patients with 0 HLA-A,B,DR mismatches. Use of administrative claims revealed similar rates of cardiovascular complications. However, HLA-matched deceased donor recipients received lower dosages of mycophenolate mofetil and manifested a lower risk of developing posttransplant diarrhea.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013880095

Download citation: RISBibTeXText

PMID: 17509448

DOI: 10.1016/j.humimm.2007.02.004


Related references

Human leukocyte antigen matching and recurrence of histologic hepatitis C in liver transplant allografts. Gastroenterology 110(4 Suppl. ): A1157, 1996

Effect of human leukocyte antigen-C and -DQ matching on pediatric heart transplant graft survival. Journal of Heart and Lung Transplantation 33(12): 1282-1287, 2014

The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. Clinical Transplantation 32(10): E13388, 2018

Impact of human leukocyte antigen matching in liver transplantation. Transplantation 75(1): 132-137, 2003

Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival. Circulation. Heart Failure 7(4): 605-611, 2014

Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. American Journal of Transplantation 4(4): 537-543, 2004

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts. Biology of Blood and Marrow Transplantation 23(1): 126-133, 2017

Negative impact of human leukocyte antigen matching in the outcome of polyomavirus nephropathy. Transplantation 80(2): 276-278, 2005

Impact of human leukocyte antigen matching on graft survival after lung transplantation. Journal of Heart & Lung Transplantation 21(1): 169-170, 2002

Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantation. Hepatobiliary and Pancreatic Diseases International 9(2): 139-143, 2010

Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clinical Transplantation 26(4): E428-E437, 2013

Using high-resolution human leukocyte antigen typing of 11,423 randomized unrelated individuals to determine allelic varieties, deduce probable human leukocyte antigen haplotypes, and observe linkage disequilibria between human leukocyte antigen-B and-C and human leukocyte antigen-DRB1 and-DQB1 alleles in the Taiwanese Chinese population. Ci Ji Yi Xue Za Zhi 29(2): 84-90, 2017

Lack of impact of human leukocyte antigen matching in living donor kidney transplantation: experience at Akdeniz University. Transplantation Proceedings 37(7): 2969-2972, 2005

Impact of human leukocyte antigen mismatch on lung transplant outcome. Interactive Cardiovascular and Thoracic Surgery 26(5): 859-864, 2018

Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biology of Blood and Marrow Transplantation 21(1): 4-7, 2015